Cryosite Limited
CTE
Rank in Stocks
#23551
Cryosite Limited, founded in 1999 and headquartered in South Granville,... Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions. Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation. The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.
Share Price
$0.83788967
Last synced: 2026-11-09
Market Cap
$40.90M
Change (1 day)
-0.96%
Change (1 year)
6.80%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cryosite Limited (CTE)
Category
Healthcare
EPS for Cryosite Limited (CTE)
EPS as of June 2026 TTM: $0.03
According to Cryosite Limited's latest financial reports, its current EPS (TTM) is $0.03. At the end of 2025 the company had an EPS of $0.03, equal to its 2024 EPS of $0.03.
EPS history for Cryosite Limited from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.03 | 7.67% |
| 2025 | $0.03 | 0.79% |
| 2024 | $0.03 | 30.57% |
| 2023 | $0.02 | 0.52% |
| 2022 | $0.02 | 84.62% |
| 2021 | $0.01 | -52.29% |
| 2020 | $0.02 | -356.47% |
| 2019 | $-0.01 | 117.95% |
| 2018 | 0.00 | 69.57% |
| 2017 | 0.00 | -147.92% |
| 2016 | 0.00 | -36.00% |
| 2015 | $0.01 | -26.47% |
| 2014 | $0.01 | -58.37% |
| 2013 | $0.02 | 9.38% |
| 2012 | $0.02 | 198.67% |
| 2011 | $0.01 | 7,400.00% |
| 2010 | 0.00 | -50.00% |
| 2009 | 0.00 | -97.92% |
| 2008 | $0.01 | -43.53% |
| 2007 | $0.02 | 962.50% |
| 2006 | 0.00 | -115.24% |
| 2005 | $-0.01 | -41.01% |
| 2004 | $-0.02 | -14.83% |
| 2003 | $-0.02 | 13.59% |
| 2002 | $-0.02 | 36.30% |
| 2001 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | 58,692.57% |
US
|
|
| $6.12 | 18,847.37% |
US
|
|
| $1.38 | 4,163.47% |
CN
|
|
| $14.83 | 45,813.31% |
US
|
|
| $5.09 | 15,658.51% |
US
|
Questions about Cryosite Limited's earnings per share (EPS)
What is Cryosite Limited's earnings per share (EPS)?
Cryosite Limited's earnings per share (EPS) over the last twelve months is $0.03, as of Jun 2026.
What was Cryosite Limited's earnings per share (EPS) in 2025?
In 2025, Cryosite Limited's earnings per share (EPS) was $0.03, about the same as in 2024 ($0.03).
How has Cryosite Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cryosite Limited's earnings per share (EPS) went from $0.02 to $0.03, an average growth of 8.45% a year.
How does Cryosite Limited's earnings per share (EPS) compare with similar companies?
Cryosite Limited's earnings per share (EPS) ($0.03) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.